AP
AGN

Atwood & Palmer’s Allergan plc AGN Stock Holding History

Atwood & Palmer’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-150
Closed -$27K – 334
2020
Q1 		$27K Hold
150
– – ﹤0.01% 208
2019
Q4 		$29K Hold
150
– – ﹤0.01% 207
2019
Q3 		$25K Hold
150
– – ﹤0.01% 222
2019
Q2 		$25K Hold
150
– – ﹤0.01% 213
2019
Q1 		$22K Hold
150
– – ﹤0.01% 213
2018
Q4 		$20K Hold
150
– – ﹤0.01% 213
2018
Q3 		$29K Sell
150
-6
-4% -$1.1K ﹤0.01% 209
2018
Q2 		$26K Buy
+156
New +$25K ﹤0.01% 216
2016
Q1 		– Sell
-41
Closed -$13K – 408
2015
Q4 		$13K Sell
41
-36
-47% -$10.7K ﹤0.01% 311
2015
Q3 		$21K Hold
77
– – ﹤0.01% 269
2015
Q2 		$23K Buy
77
+36
+88% +$10.7K ﹤0.01% 235
2015
Q1 		$12K Hold
41
– – ﹤0.01% 260
2014
Q4 		$11K Hold
41
– – ﹤0.01% 292
2014
Q3 		$10K Buy
+41
New +$9.18K ﹤0.01% 310

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Atwood & Palmer's AGN Position: Q2 2020 in Review

Atwood & Palmer sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 150 shares — an estimated $27K sold.

Atwood & Palmer first reported a position in AGN in Q3 2014 and held it in 14 quarters. The position peaked at $29K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Atwood & Palmer reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Atwood & Palmer sold 150 Allergan plc shares in Q2 2020, an estimated $27K.
  • Atwood & Palmer first reported a position in Allergan plc in Q3 2014 and held it in 14 quarters.
  • Atwood & Palmer's Allergan plc position peaked at $29K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Atwood & Palmer's 13F filing for Q2 2020, filed 24 Jul 2020.